These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17991195)

  • 1. The cholesterol paradox is flawed; cholesterol must be lowered in dialysis patients.
    Wan RK; Mark PB; Jardine AG
    Semin Dial; 2007; 20(6):504-9. PubMed ID: 17991195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is lipid control necessary in hemodialysis patients?
    Cheung AK
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S95-101. PubMed ID: 19996012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next?
    Kalantar-Zadeh K
    Semin Dial; 2005; 18(5):365-9. PubMed ID: 16191172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines.
    Shoji T; Nishizawa Y
    Ther Apher Dial; 2006 Aug; 10(4):305-15. PubMed ID: 16911182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome.
    Kovesdy CP; Anderson JE; Kalantar-Zadeh K
    J Am Soc Nephrol; 2007 Jan; 18(1):304-11. PubMed ID: 17167114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic inflammation and cardiovascular risk in hemodialysis].
    Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G
    G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Statins in chronic renal disease].
    Ferreira SR; Rocha AM; Saraiva JF
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():45-9. PubMed ID: 16400399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a reversal of reverse epidemiology in renal transplant recipients?
    Chavalitdhamrong D; Danovitch GM; Bunnapradist S
    Semin Dial; 2007; 20(6):544-8. PubMed ID: 17991202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse epidemiology: paradoxical observations in haemodialysis patients.
    Nurmohamed SA; Nubé MJ
    Neth J Med; 2005 Nov; 63(10):376-81. PubMed ID: 16301758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidemia, inflammation and dialysis outcomes: what we know now.
    Krane V; Drechsler C; Wanner C
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):566-70. PubMed ID: 17053468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of lipid abnormalities associated with end-stage renal disease.
    Liu J; Kalantarinia K; Rosner MH
    Semin Dial; 2006; 19(5):391-401. PubMed ID: 16970739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renal patient with cardiovascular disease--no longer a simple plumbing problem.
    Tunuguntla A; Yerra L
    Tenn Med; 2005 Aug; 98(8):395-6, 399. PubMed ID: 16315466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol in end-stage renal disease: the good, the bad or the ugly?
    Diepeveen SH; Wetzels JF; Bilo HJ; van Tits LJ; Stalenhoef AF
    Neth J Med; 2008 Feb; 66(2):53-61. PubMed ID: 18292607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
    Kanbay M; Turgut F; Covic A; Goldsmith D
    J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse epidemiology in hemodialysis patients. Lessons from Japanese registries.
    Shoji T; Tsubakihara Y; Nakai S; Nishizawa Y
    Nephrol Ther; 2008 Jul; 4(4):223-7. PubMed ID: 18406224
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients.
    Suliman ME; Stenvinkel P; Bárány P; Rashid Qureshi A; Lindholm B
    Semin Nephrol; 2006 Jan; 26(1):14-9. PubMed ID: 16412819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular death in dialysis patients: lessons we can learn from AURORA.
    Sniderman AD; Solhpour A; Alam A; Williams K; Sloand JA
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):335-40. PubMed ID: 20056762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid metabolism in dialysis patients-the story gets more complicated.
    Ponda MP; Barash I
    Semin Dial; 2008; 21(5):390-4. PubMed ID: 18764791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index and cardiovascular risk factors and biomarkers in hemodialysis patients.
    Bossola M; Giungi S; Panocchia N; Vulpio C; Luciani G; Tazza L
    J Nephrol; 2008; 21(2):197-204. PubMed ID: 18446714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.